| John Harrison Irons, MD | |
|
2868 Acton Rd, Vestavia, AL 35243 | |
| (205) 332-3160 | |
| (866) 702-0880 |
| Full Name | John Harrison Irons |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 12 Years |
| Location | 2868 Acton Rd, Vestavia, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578822904 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical West, An Affiliate Of Uab Health System | Bessemer, AL | Hospital |
| Grandview Medical Center | Birmingham, AL | Hospital |
| Entity Name | Anesthesia Associates Of East Alabama Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245201771 PECOS PAC ID: 5395768451 Enrollment ID: O20060104000743 |
News Archive
Aradigm Corporation announced the last patient was enrolled in a Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (CFI, ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE), a severe progressive respiratory disease for which there is currently no approved treatment in the U.S.
SYGNIS AG today announced the launch of its Universal Lateral Flow Assay kit, the latest addition to its expanding range of lateral flow assay products and services which are being commercialized under the Expedeon brand name.
Growing evidence suggests how individuals cope with and appraise disease-related pain, such as arthritis or cancer, is related not only to their experience with pain but also to their physical and psychological functioning, according to new research presented here today in a plenary session talk at the American Pain Society's annual scientific meeting.
A research team composed of University of Kentucky researchers has published a paper which provides the first direct evidence that activated astrocytes could play a harmful role in Alzheimer's disease.
› Verified 5 days ago
| Entity Name | Cypress Healthcare, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811295215 PECOS PAC ID: 8224206388 Enrollment ID: O20110718000200 |
News Archive
Aradigm Corporation announced the last patient was enrolled in a Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (CFI, ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE), a severe progressive respiratory disease for which there is currently no approved treatment in the U.S.
SYGNIS AG today announced the launch of its Universal Lateral Flow Assay kit, the latest addition to its expanding range of lateral flow assay products and services which are being commercialized under the Expedeon brand name.
Growing evidence suggests how individuals cope with and appraise disease-related pain, such as arthritis or cancer, is related not only to their experience with pain but also to their physical and psychological functioning, according to new research presented here today in a plenary session talk at the American Pain Society's annual scientific meeting.
A research team composed of University of Kentucky researchers has published a paper which provides the first direct evidence that activated astrocytes could play a harmful role in Alzheimer's disease.
› Verified 5 days ago
| Entity Name | Southern Ketamine And Wellness Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700590007 PECOS PAC ID: 0446619845 Enrollment ID: O20230703001546 |
News Archive
Aradigm Corporation announced the last patient was enrolled in a Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (CFI, ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE), a severe progressive respiratory disease for which there is currently no approved treatment in the U.S.
SYGNIS AG today announced the launch of its Universal Lateral Flow Assay kit, the latest addition to its expanding range of lateral flow assay products and services which are being commercialized under the Expedeon brand name.
Growing evidence suggests how individuals cope with and appraise disease-related pain, such as arthritis or cancer, is related not only to their experience with pain but also to their physical and psychological functioning, according to new research presented here today in a plenary session talk at the American Pain Society's annual scientific meeting.
A research team composed of University of Kentucky researchers has published a paper which provides the first direct evidence that activated astrocytes could play a harmful role in Alzheimer's disease.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Harrison Irons, MD 2868 Acton Rd, Vestavia, AL 35243-2502 Ph: (205) 332-3160 | John Harrison Irons, MD 2868 Acton Rd, Vestavia, AL 35243 Ph: (205) 332-3160 |
News Archive
Aradigm Corporation announced the last patient was enrolled in a Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (CFI, ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE), a severe progressive respiratory disease for which there is currently no approved treatment in the U.S.
SYGNIS AG today announced the launch of its Universal Lateral Flow Assay kit, the latest addition to its expanding range of lateral flow assay products and services which are being commercialized under the Expedeon brand name.
Growing evidence suggests how individuals cope with and appraise disease-related pain, such as arthritis or cancer, is related not only to their experience with pain but also to their physical and psychological functioning, according to new research presented here today in a plenary session talk at the American Pain Society's annual scientific meeting.
A research team composed of University of Kentucky researchers has published a paper which provides the first direct evidence that activated astrocytes could play a harmful role in Alzheimer's disease.
› Verified 5 days ago